SHG:688426 - Jiangsu Cowin Biotech Co Ltd

Jiangsu Cowin Biotech Co. Ltd.
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	40.02M -53.6%	109.57M 173.8%	102.57M -6.4%	122.81M 19.7%	142.75M 16.2%	132.39M -7.3%	123.65M -6.6%	76.94M -37.8%	44.62M -42.0%	29.9M -33.0%	19.89M -33.5%	28.8M 44.8%
Cost of Revenue	[friend]	-	54.7M -	38.94M -28.8%	39.5M 1.4%	34.69M -12.2%	29.43M -15.1%	53.34M 81.2%	22.81M -57.2%	13.65M -40.1%	7.73M -43.4%	16.42M 112.3%	12.13M -26.2%
Gross Profit	[friend]	40.02M -53.6%	54.87M 37.1%	63.64M 16.0%	83.32M 30.9%	108.06M 29.7%	102.95M -4.7%	70.31M -31.7%	54.14M -23.0%	30.96M -42.8%	22.16M -28.4%	3.46M -84.4%	16.68M 381.3%
Total Expenses	[friend]	-	145.13M -	51.72M -64.4%	75.07M 45.1%	71.98M -4.1%	74.61M 3.7%	104.87M 40.6%	68.34M -34.8%	70.52M 3.2%	62.21M -11.8%	75.52M 21.4%	63.76M -15.6%
Operating Expense	[friend]	-	90.43M -	12.78M -85.9%	35.57M 178.3%	37.29M 4.9%	45.18M 21.1%	51.53M 14.1%	45.53M -11.6%	56.87M 24.9%	54.48M -4.2%	59.1M 8.5%	51.63M -12.6%
Operating Income	[friend]	40.02M -53.6%	-35.56M -	50.86M -	47.75M -6.1%	70.77M 48.2%	57.78M -18.4%	18.78M -67.5%	8.61M -54.2%	-25.9M -	-32.32M -	-55.63M -	-34.95M -
Net Income (Cont Operations)	[friend]	-	-	-	-	100.92M -	-	-	-	-4.36M -	-	-	-
Net Income	[friend]	4.67M -87.2%	45.21M 869.2%	39.41M -12.8%	38.88M -1.3%	61.18M 57.3%	45.19M -26.1%	14M -69.0%	3.99M -71.5%	-13.86M -	-25.67M -	-48.86M -	-28.97M -
Basic EPS	[friend]	0.056 -87.2%	0.539 869.2%	0.467 -13.5%	0.517 10.7%	0.915 77.2%	0.648 -29.2%	0.125 -80.7%	0.04 -67.9%	-0.15 -	-0.25 -	-0.392 -	-0.26 -
Diluted EPS	[friend]	0.056 -87.2%	0.539 869.2%	0.458 -15.0%	0.508 10.9%	0.915 80.1%	0.648 -29.2%	0.125 -80.7%	0.04 -67.9%	-0.15 -	-0.25 -	-0.392 -	-0.26 -